High immunoexpression of progesterone-induced blocking factor (PIBF) in endometrial cancer
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Purpose of Investigation: This study aims to investigate PIBF expression levels in normal, hyperplastic, and endometrioid adenocarcinoma paraffin blocks. The purpose of this study is to determine the PIBF expression levels in endometrial cancer cells. Materials and Methods: A total of 90 patients were investigated. Thirty of those were diagnosed as having normal endometrial tissue, 30 had endometrial hyperplasia, and 30 had endometrioid adenocarcinoma. The expression of PIBF was assessed using immunohistochemically using paraffin-embedded tissue blocks. Results: Tissue sections were compared based on immunostaining with PIBF. The authors detected higher stromal PIBF expression in the endometrioid adenocarcinoma group as compared to the endometrial hyperplasia and normal endometrium groups (p < 0.001). The glandular PIBF expression did not differ among the groups (p > 0.05). Conclusions: Endometrial cancer cells have higher levels of expression of PIBF protein than normal endometrial tissue and endometrial hyperplasia tissue based on immunohistochemistry staining. PIBF immunostaining may be helpful in preoperatively differentiating between atypical endometrial hyperplasia (AEH) and endometrioid adenocarcinoma (EC) in suspicious cases.
Authors and Affiliations
E. Sahin, Y. Madendag, M.E. Sahin, I. C. Madendag, A. T. Tayyar, F. Senel, H. Karaman, G. Acmaz
Keywords
Related Articles
- EP ID EP663033
- DOI 10.12892/ejgo4338.2019
- Views 69
- Downloads 0
Survival rate and complications after different types of pelvic exenteration for gynecological cancer
Pelvic exenteration (PE) is an operative method for one-moment removal of pelvic organs, including reproductive tract, bladder, and rectosidgmoid. It is most commonly indicated in gynecologic oncology for treatment of lo...
Surgical management of recurrent gynecological cancer: Complete resection is the key to longer survival
Summary Purpose of investigation: This study was conducted to elucidate the efficacy and feasibility of surgical management of recurrent gynecological (cervical, endometrial, and ovarian) cancers. Materials and Methods:...
The role of erythropoietin and erythropoietin receptor expression in breast cancer
Erythropoietin (EPO) plays a number of important functions in the body. Contrary to original beliefs, its activity is not limited to exerting effects on cells along the erythropoietic pathway. Newly published results con...
Immunohistochemical analysis of IQGAP2 in ovarian cancer
IQ motif-containing GTPase-activating protein 2 (IQGAP2) was regarded as a tumor suppressor in some cancers, but its expression pattern in various histological subtypes of ovarian cancer has not been investigated. Immuno...
The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro
Purpose of investigation: The pleiotropic factor Y-box binding protein-1 (YB-1) is clinically correlated with breast cancer patients’ poor outcome. Due to the intereference of YB-1 with the estrogen receptor, the authors...